- Home
- SHFS vs NCNA Comparison
SHFS vs NCNA Comparison
Compare SHFS & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- NCNA
- Stock Information
- Founded
- SHFS 2015
- NCNA 1997
- Country
- SHFS United States
- NCNA United Kingdom
- Employees
- SHFS N/A
- NCNA N/A
- Industry
- SHFS Finance: Consumer Services
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- SHFS Finance
- NCNA Health Care
- Exchange
- SHFS Nasdaq
- NCNA Nasdaq
- Market Cap
- SHFS 6.3M
- NCNA 6.6M
- IPO Year
- SHFS N/A
- NCNA 2017
- Fundamental
- Price
- SHFS $3.25
- NCNA $3.96
- Analyst Decision
- SHFS
- NCNA
- Analyst Count
- SHFS 0
- NCNA 0
- Target Price
- SHFS N/A
- NCNA N/A
- AVG Volume (30 Days)
- SHFS 2.3M
- NCNA 451.8K
- Earning Date
- SHFS 11-11-2025
- NCNA 08-20-2025
- Dividend Yield
- SHFS N/A
- NCNA N/A
- EPS Growth
- SHFS N/A
- NCNA N/A
- EPS
- SHFS N/A
- NCNA N/A
- Revenue
- SHFS $11,720,493.00
- NCNA N/A
- Revenue This Year
- SHFS N/A
- NCNA N/A
- Revenue Next Year
- SHFS N/A
- NCNA N/A
- P/E Ratio
- SHFS N/A
- NCNA N/A
- Revenue Growth
- SHFS N/A
- NCNA N/A
- 52 Week Low
- SHFS $1.84
- NCNA $2.78
- 52 Week High
- SHFS $11.80
- NCNA $1,182.00
- Technical
- Relative Strength Index (RSI)
- SHFS 47.66
- NCNA 43.35
- Support Level
- SHFS $3.87
- NCNA $2.82
- Resistance Level
- SHFS $4.47
- NCNA $4.88
- Average True Range (ATR)
- SHFS 0.57
- NCNA 0.31
- MACD
- SHFS -0.03
- NCNA 0.46
- Stochastic Oscillator
- SHFS 41.54
- NCNA 55.95
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.